SofPulse
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6320 Canoga Ave Fl 15, Woodland Hills, C...Phone Number
(800) 701-1223Website
www.sofpulse.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SofPulse
Endonovo Therapeutics, Inc. offers SofPulse, a targeted pulsed electromagnetic field (tPEMF) therapy device designed to reduce pain and swelling while accelerating the healing process. This FDA-cleared medical device is clinically proven to enhance recovery and minimize the reliance on pain medications. The technology is suitable for both clinicians and patients, allowing for integration into treatment protocols and enabling patients to continue healing at home. SofPulse is particularly beneficial for post-surgical pain, inflammation, wound healing, and orthopedic conditions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SofPulse your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once SofPulse has new funding data
Congratulate Masked Content for being promoted to Masked Content at SofPulse
Check if SofPulse has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on SofPulse recently announced quarterly report
Click to see if SofPulse had a recent Job posting/layoffs
Product Launch: Get notified when SofPulse launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
SofPulse, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if SofPulse is spiking on competitors!
Recommended Actions
Find VP level buyers at SofPulse
Find 2 more new buyers
Compare Similar Companies to SofPulse
Compare insights from companies similar to SofPulse, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SofPulse
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
SofPulse is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SofPulse is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SofPulse.
SofPulse Tech Stack
A closer look at the technologies used by SofPulse
SofPulse News & Media
Endonovo's SofPulse® Secures Taiwan FDA Approval
Los Angeles, CA, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) US-based medical device company, today announced the full regulatory approval of its flagship product, SofPulse® by the Taiwan Food and Drug Administration (TFDA), the regulatory division of the Ministry of Health and Welfare (MOHW).Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company
Los Angeles, CA, March 29, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced a binding Letter of Intent (LOI) to spin off its current medical device division to an entity controlled by Ira Weisberg, who will be the future President and CEO of a newly formed publicly-traded Delaware company, tentatively named SofPulse, Inc.Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulse® Devices Moves Forward
Los Angeles, CA, May 11, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced completion of Shipment of SofPulse® tPEMF Devices for use in a Stanford University sponsored Orthopedic Shoulder and Knee Study. The Stanford Orthopedic study titled, ‘Pulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery’ is scheduled for a final completion date of August 2022. The Orthopedic interventional (clinicalEndonovo Therapeutics Announces International Expansion with Distribution Agreement for SofPulse® in Taiwan, Republic of China
Los Angeles, CA, June 01, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the signing of a Sales and Strategic Partnership Agreement with Evermed Medical Enterprise Ltd., a leading medical device distributor in Taiwan, ROC (Republic of China) to distribute SofPulse®.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SofPulse
Sign Up For FreeTo access detailed company insights
Endonovo Therapeutics, Inc. offers SofPulse, a targeted pulsed electromagnetic field (tPEMF) therapy device designed to reduce pain and swelling while accelerating the healing process. This FDA-cleared medical device is clinically proven to enhance recovery and minimize the reliance on pain medications. The technology is suitable for both clinician... Read More
